News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results